29.3200.00% ( 0.000 )
Delay Suspended: Nov 17, 09:29:26Profile
About

AB&B BIO-TECH-B
02627.HK
Ab&B Bio-Tech CO., LTD. JS engages in the research, development, manufacturing, and commercialization of vaccines in China. The company offers quadrivalent subunit influenza and trivalent subunit influenza vaccines. Its product pipeline also includes lyophilized human rabies, pneumococcal polysaccharide vaccine 23, and recombinant zoster vaccine which is in phase I clinical trial; and adjuvanted quadrivalent subunit influenza, adjuvanted trivalent subunit influenza, recombinant RSV, mRNA mpox, mRNA respiratory syncytial virus (RSV), pneumococcal conjugate vaccine 24, live attenuated varicella, and tetanus toxoid adsorbed vaccines which is in preclinical trial.
Profile
- Company Name
- Ab&B Bio-Tech CO., LTD. JS
- Market
- SEHK
- Founded
- Industry
- --
- Fiscal Year End
- --
- Website
- www.abbbio.com
Related Securities
Industry
Industry RankingsValueRank
Management
NamePosition
